Archives for November 16, 2020

← 2020
October sees boost for biotech funding

October sees boost for biotech funding

By Jane Byrne

Biotech funding kicked back into higher gear in October, pushing toward the summer monthly record highs with $10.5B raised, writes analyst firm, Jefferies

J&J launches Phase 3 trial for 2-dose COVID-19 vaccine

J&J launches Phase 3 trial for 2-dose COVID-19 vaccine

By Rachel Arthur

Johnson & Johnson has launched a second global Phase 3 trial for its Janssen COVID-19 vaccine candidate: this time exploring a 2-dose regimen (its existing Phase 3 trial is for a 1-dose regimen).